Page last updated: 2024-08-24

aripiprazole and Akinetic-Rigid Variant of Huntington Disease

aripiprazole has been researched along with Akinetic-Rigid Variant of Huntington Disease in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's5 (71.43)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Edlinger, M; Fleischhacker, W; Hofer, A; Seppi, K1
Alnıak, İ; Ulusoy, S; Yavuz, KF1
Howard, AK; Krishnamoorthy, A; Leavitt, BR; Raymond, LA; Weissman, CR1
Chou, YH; Lin, WC1
Bernardi, G; Brusa, L; Iani, C; Mercuri, NB; Moschella, V; Orlacchio, A1
Abler, B; Gahr, M; Orth, M1
Konstantakopoulos, G; Kouzoupis, AV; Mourikis, I; Oulis, P; Papageorgiou, SG1

Trials

1 trial(s) available for aripiprazole and Akinetic-Rigid Variant of Huntington Disease

ArticleYear
Treatment of the symptoms of Huntington's disease: preliminary results comparing aripiprazole and tetrabenazine.
    Movement disorders : official journal of the Movement Disorder Society, 2009, Jan-15, Volume: 24, Issue:1

    Topics: Adult; Aged; Aripiprazole; Cross-Over Studies; Dopamine Agents; Dyskinesia, Drug-Induced; Female; Humans; Huntingtin Protein; Huntington Disease; Hyperkinesis; Male; Middle Aged; Nerve Tissue Proteins; Nuclear Proteins; Piperazines; Quinolones; Receptors, Dopamine D2; Tetrabenazine; Trinucleotide Repeats

2009

Other Studies

6 other study(ies) available for aripiprazole and Akinetic-Rigid Variant of Huntington Disease

ArticleYear
Treatment of psychotic and behavioral symptoms with clozapine, aripiprazole, and reboxetine in a patient with Huntington's disease.
    International clinical psychopharmacology, 2013, Volume: 28, Issue:4

    Topics: Adult; Aggression; Antipsychotic Agents; Aripiprazole; Clozapine; Drug Therapy, Combination; Humans; Huntington Disease; Male; Morpholines; Piperazines; Psychotic Disorders; Quinolones; Reboxetine; Treatment Outcome

2013
Aripiprazole treatment for choreoathetoid and psychotic symptoms of Huntington's disease.
    The Journal of neuropsychiatry and clinical neurosciences, 2013,Spring, Volume: 25, Issue:2

    Topics: Antipsychotic Agents; Aripiprazole; Athetosis; Chorea; Humans; Huntington Disease; Piperazines; Psychotic Disorders; Quinolones

2013
Treatment of Huntington Disease and Comorbid Trichotillomania With Aripiprazole.
    The Journal of neuropsychiatry and clinical neurosciences, 2015,Summer, Volume: 27, Issue:3

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Female; Humans; Huntington Disease; Trichotillomania

2015
Aripiprazole effects on psychosis and chorea in a patient with Huntington's disease.
    The American journal of psychiatry, 2008, Volume: 165, Issue:9

    Topics: Antipsychotic Agents; Aripiprazole; Humans; Huntington Disease; Male; Middle Aged; Piperazines; Psychotic Disorders; Quinolones

2008
Neuroleptic malignant syndrome with aripiprazole in Huntington's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2010, Oct-30, Volume: 25, Issue:14

    Topics: Antipsychotic Agents; Aripiprazole; Humans; Huntington Disease; Male; Middle Aged; Neuroleptic Malignant Syndrome; Piperazines; Quinolones

2010
Aripiprazole in the treatment of olanzapine-resistant psychotic and motor symptoms of Huntington's disease.
    The Journal of neuropsychiatry and clinical neurosciences, 2010,Summer, Volume: 22, Issue:3

    Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Humans; Huntington Disease; Male; Middle Aged; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones; Treatment Outcome

2010